Sankala Group’s New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF LRND Stock Holding History
Bought
Maintained
Sold
Other funds holding LRND
NYLIM
Sankala Group's LRND Position: Q2 2026 in Review
Sankala Group increased its New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) stake by 42% in Q2 2026, buying an estimated $10.3K and bringing the position to 810 shares worth $37.5K. The position accounts for 0.03% of the portfolio, ranked #275.
Sankala Group first reported a position in LRND in Q4 2025 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold LRND as of Q2 2026.
- Sankala Group held 810 shares of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF worth $37.5K as of Q2 2026.
- Sankala Group bought 240 New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF shares in Q2 2026, an estimated $10.3K.
- New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF made up 0.03% of Sankala Group's portfolio in Q2 2026, its #275 holding.
- Sankala Group first reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in Q4 2025 and has held it in 3 quarters since.
- 6 funds tracked by Wall St. Rank held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF as of Q2 2026.
Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.